Authors
Head of Technology Auditing & Compliance, UCB Pharma
Vice President and Unit Head, Oncology Global Therapeutic Delivery, IQVIA
Assistant Director, Data Sciences and Analytics, with Tufts Center for the Study of Drug Development (Tufts CSDD)
With MD Anderson Cancer Center
Director, Central Monitoring, CluePoints
Chief Operating Officer, TransCelerate BioPharma
Special Counsel, Tax Controversy and Litigation Practice, Chamberlain Hrdlicka
Senior Director, Commercialization, IQVIA Technologies
Project Manager, Senior Research Consultant with Tufts Center for the Study of Drug Development (Tufts CSDD)
Senior Director, Medidata Solutions
Director Solution Engineering, IQVIA Patient Suite, IQVIA Technologies